Mental health is at a low point in the U.S., even as more people seek out treatment. From 2019 to 2022, use of mental health care services increased 38.8% among about 7 million adults with private health insurance. Spending on such services also jumped — by 53.7% — during that time, according to a study… Read More »
With its $ 63 billion merger with Allergan in the rearview, the new AbbVie is facing a major challenge as U.S. biosimilars for Humira cast a pall over the near-term future. But AbbVie figures its homegrown prospects will keep driving growth—and a couple of surprises from Allergan could make the forecast even rosier. After six… Read More »
If you’re on Instagram or if you’ve taken the New York City subway lately, chances are you’ve heard of Hims, the men’s health and wellness company with a penchant for advertisements featuring suggestive cacti and eggplants against pastel backgrounds. The web-based startup targets the young male demographic with skincare products, multivitamins, and erectile dysfunction medications. In January, just a few… Read More »